Nonetheless, anti-CD19 CAR T-cell therapy is introducing a new treatment paradigm and is increasingly being considered a potentially curative approach for various autoimmune diseases, bringing new hope to patients (Figure 3). This evidence concerns the gene CD19 and autoimmune disease.